Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2924129rdf:typepubmed:Citationlld:pubmed
pubmed-article:2924129lifeskim:mentionsumls-concept:C0001792lld:lifeskim
pubmed-article:2924129lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:2924129lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:2924129lifeskim:mentionsumls-concept:C0019564lld:lifeskim
pubmed-article:2924129lifeskim:mentionsumls-concept:C0041904lld:lifeskim
pubmed-article:2924129lifeskim:mentionsumls-concept:C0221099lld:lifeskim
pubmed-article:2924129lifeskim:mentionsumls-concept:C0162493lld:lifeskim
pubmed-article:2924129lifeskim:mentionsumls-concept:C0034795lld:lifeskim
pubmed-article:2924129pubmed:issue2lld:pubmed
pubmed-article:2924129pubmed:dateCreated1989-4-28lld:pubmed
pubmed-article:2924129pubmed:abstractTextSeveral recent investigations have reported a decline of rat hippocampal corticosteroid-binding receptors (CSRs) with aging. This decline has been proposed to be an initial cause (through disinhibition) of the elevated adrenal steroid secretion that apparently occurs with aging; however, it could instead be an effect of corticoid elevation (through down-regulation). In order to assess the effects of age on CSR biosynthetic capacity in the absence of down-regulatory influences of endogenous corticoids, as well as to study aging changes in CSR plasticity, we examined the up-regulation of hippocampal CSR that follows adrenalectomy (ADX). The rat hippocampus contains at least two types of CSR binding and differential analysis of types I and II CSR was accomplished by selective displacement of [3H]corticosterone with RU-28362, a specific type II agonist. In young (3 months old) Fischer-344 rat hippocampus, up-regulation of type II binding above 2-day ADX baseline was present by 3-7 days and increased still further by 8-10 days post-ADX; type I CSR density did not change significantly between 1 and 10 days post-ADX. However, in aged (24-26 months old) rats, type II CSR up-regulation did not occur over the 10 day post-ADX period. Thus, the age-related impairment of type II up-regulation may reflect an intrinsic deficit in CSR biosynthesis or lability that is independent of the acute endogenous adrenal steroid environment.lld:pubmed
pubmed-article:2924129pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2924129pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2924129pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2924129pubmed:languageenglld:pubmed
pubmed-article:2924129pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2924129pubmed:citationSubsetIMlld:pubmed
pubmed-article:2924129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2924129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2924129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2924129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2924129pubmed:statusMEDLINElld:pubmed
pubmed-article:2924129pubmed:monthJanlld:pubmed
pubmed-article:2924129pubmed:issn0006-8993lld:pubmed
pubmed-article:2924129pubmed:authorpubmed-author:EldridgeJ CJClld:pubmed
pubmed-article:2924129pubmed:authorpubmed-author:LandfieldP...lld:pubmed
pubmed-article:2924129pubmed:authorpubmed-author:KerrD SDSlld:pubmed
pubmed-article:2924129pubmed:authorpubmed-author:FleenorD GDGlld:pubmed
pubmed-article:2924129pubmed:issnTypePrintlld:pubmed
pubmed-article:2924129pubmed:day30lld:pubmed
pubmed-article:2924129pubmed:volume478lld:pubmed
pubmed-article:2924129pubmed:ownerNLMlld:pubmed
pubmed-article:2924129pubmed:authorsCompleteYlld:pubmed
pubmed-article:2924129pubmed:pagination248-56lld:pubmed
pubmed-article:2924129pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2924129pubmed:meshHeadingpubmed-meshheading:2924129-...lld:pubmed
pubmed-article:2924129pubmed:meshHeadingpubmed-meshheading:2924129-...lld:pubmed
pubmed-article:2924129pubmed:meshHeadingpubmed-meshheading:2924129-...lld:pubmed
pubmed-article:2924129pubmed:meshHeadingpubmed-meshheading:2924129-...lld:pubmed
pubmed-article:2924129pubmed:meshHeadingpubmed-meshheading:2924129-...lld:pubmed
pubmed-article:2924129pubmed:meshHeadingpubmed-meshheading:2924129-...lld:pubmed
pubmed-article:2924129pubmed:meshHeadingpubmed-meshheading:2924129-...lld:pubmed
pubmed-article:2924129pubmed:meshHeadingpubmed-meshheading:2924129-...lld:pubmed
pubmed-article:2924129pubmed:meshHeadingpubmed-meshheading:2924129-...lld:pubmed
pubmed-article:2924129pubmed:meshHeadingpubmed-meshheading:2924129-...lld:pubmed
pubmed-article:2924129pubmed:meshHeadingpubmed-meshheading:2924129-...lld:pubmed
pubmed-article:2924129pubmed:meshHeadingpubmed-meshheading:2924129-...lld:pubmed
pubmed-article:2924129pubmed:year1989lld:pubmed
pubmed-article:2924129pubmed:articleTitleImpaired up-regulation of type II corticosteroid receptors in hippocampus of aged rats.lld:pubmed
pubmed-article:2924129pubmed:affiliationDepartment of Physiology and Pharmacology, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC 27103.lld:pubmed
pubmed-article:2924129pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2924129pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2924129lld:pubmed